The Saudi Food and Drug Authority fined 34 pharmacutical establishments more than SAR 4 million during January 2026 for failing to comply with the electronic tracking system for registered pharmaceutical products (Rasd).
11 Establishments
Did not commit to providing their registered products, whether locally manufactured or imported.
13 Establishments
Did not commit to reporting expected shortages or supply interruptions at least 6 months in advance, or the expected impact on stock.
2 Establishments
Did not maintain sufficient permanent stock for 6 months of all registered products, nor compensate any shortage within 3 months as a maximum limit.
8 Establishments
Did not commit to immediate reporting of drug movement.
Total Fines: SAR 4,175,400
The “Rasd” system works to track and monitor all human medicines from manufacturing until they reach the consumer, using the latest technologies to ensure availability, drug safety, and combat commercial fraud.
According to the Pharmaceutical and Herbal Establishments Regulation, penalties may reach up to SAR 5 million, in addition to temporary closure of the establishment for up to 180 days and/or license cancellation.